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ABSTRACT 
Objectives: To understand the patterns of healthcare service utilization in employees with 
multimorbidity. 
Methods: Data were obtained from the 2011-2012 cross-sectional Australian National Health 
Survey. Past-month healthcare service utilization was collected for each chronic conditions 
from a pre-specified list. Descriptive, logistic, and Poisson regression analyses were used. 
The data were weighted to produce nationally representative estimates.  
Results: Multimorbid employees with arthritis had higher adjusted arthritis-specific GP visit 
rates (RR=1.7, 95% CI=1.1-2.2, p<0.001) than employees with arthritis alone. Similarly, 
multimorbid employees with CVD had higher adjusted CVD-specific specialist visit rates 
(RR=1.6, 95% CI=1.1-2.5, p<0.05) and 2.5 times (95% CI=1.5-4.0, p<0.001) more CVD-
specific other health professional visits than employees with CVD alone.  
Conclusions: Given the increasing number of employees managing work and chronic 
illnesses, these findings have implications for health services and employers. 
 
INTRODUCTION 
Multimorbidity, or the presence of multiple chronic conditions in one individual, is a 
major public health concern1-3 due to its increasing prevalence, associated cost, and often 
complex medical management.4 Multimorbidity is more common in older age groups2 5. 
However, more than half of individuals with multimorbidity are younger than 65 years of age 
(i.e., of working age)6. The earlier onset of chronic conditions also implies younger persons 
are more likely to experience subsequent chronic conditions3 7. Most direct healthcare costs in 
health systems are spent on treating multimorbidity4 8. In addition employees, who represent 
63.4% of the global population, are working longer than before, even though have reached 
their retirement age9. For example, the Australian labour force participation rate for 
individuals aged 55+ years rose from 23% in 1984 to 35% in 2014,10 and one fifth of 
Australian adults had multimorbidity10. Therefore, multimorbidity has become a substantial 
and challenging health and economic issue for the current workforce.  
People with multimorbidity have higher overall health service utilization, including 
more frequent and longer hospitalizations, readmissions, and physician visits, than people 
with a single condition1 2 5 11-13. However, healthcare service utilization is multifactorial and 
potentially subject to measurement error14. The more health conditions a person experiences, 
the higher the risk of measurement error. As healthcare is still predominately delivered 
according to the individual diseases2, it is useful to understand healthcare service utilisation 
patterns for diseases when they are multimorbid versus not. Additionally, most studies have 
focused on higher risk populations, such as patients who frequently use healthcare services 
and the elderly, who are more likely to present with multimorbidity15. As a productive 
workforce is central to the economic well-being of a country, understanding how employees 
use healthcare services for single diseases in the context of multimorbidity is essential. 
Particularly to gain the insights into their healthcare demands and reduce the consequences of 
multimorbidity on the workforce, including absenteeism, presenteeism and the related lost 
productive time. However, we were unable to locate any studies that reported the associations 
between multimorbidity and disease-specific healthcare service utilization, which referred to 
a series of single-disease evaluations, particularly in the workforce. 
Until recently, the definition of multimorbidity and the included number of health 
conditions studies varied across the studies as no agreed definition existed3. Some 
international institutes, such as the Academy of Medical Sciences16 are calling for evidence to 
progress a consistent definition of multimorbidity. The consequence of no unique definition 
makes the comparison between studies challenging. Therefore, it is critical to specify the 
definition of multimorbidity and the included number of health conditions in the studies 
focusing on multimorbidity.  
The aim of this study was to examine the association of multimorbidity with disease-
specific healthcare service utilization in a working population. Specifically, we sought to: i) 
characterize employees with a specific chronic condition in terms of their health statuses 
(with or without multimorbidity); and ii) determine the associations between the presence of 
multimorbidity and disease-specific healthcare service utilization among employees. 
 
METHODS 
Data were derived from the nationally representative, cross-sectional Australian 
National Health Survey (NHS), which was conducted from March 2011 to March 2012.17 
Initially, 21,108 private dwellings were selected in the sample. This number was reduced to 
18,355 due to sample loss in the field stage17. Of these dwellings, 15,565 (84.8%) were fully 
or adequately responding households, including 20,426 persons aged 0 years and over17. 
Under or over-representation of particular demographic groups, such as working people 
(under-represented as the survey was conducted in private dwellings), was adjusted to ensure 
sample representativeness17. 
The NHS dataset contains self-reported information on the labour force status and 
healthcare service utilization for each current chronic disease in the 12 months prior to the 
face-to-face interviews conducted among respondents aged 15 years and over17. Respondents 
were classified as employed, unemployed, or not in the labour force using the reduced set of 
the questions from the Australian Bureau of Statistics (ABS) Monthly Labour Force Survey17. 
Employed respondents were identified when they had worked in a job, for a business, or on a 
farm in the past week, or had a job but were absent during that week17. However, respondents 
whose usual work time was less than one hour, unpaid voluntary work, and those who were 
away from work due to workers’ compensation but were unsure whether they would return to 
work for their employers were excluded17. Therefore, for the purpose of this study, 
respondents aged 15 years and older who were currently employed at the time of interview 
were included. 
Multimorbidity was defined as the concurrent presence of two or more diagnosed 
chronic conditions18-20. Eight diagnosed chronic conditions that had lasted, or were expected 
to last, six months or more based on a computer-based coding system developed by the ABS 
were collected, including asthma, cancer, cardiovascular disease (CVD), arthritis, 
osteoporosis, diabetes (type 2, type 1 and unspecified type-excluding diabetes which was not 
current, long-term and diagnosed, such as gestational diabetes and diabetes insipidus), kidney 
disease, and mental well-being; these conditions were the most commonly experienced and 
were relevant to policy planning in the Australian community. The aforementioned 
conditions were identified as chronic medical conditions by asking whether the patient had 
“ever been told by a doctor or nurse, still current and long-term” and then by asking whether 
“had lasted at least six months or the respondent expected the condition to last six months or 
longer”. There were exceptions for some conditions (e.g., asthma was considered even if the 
respondent reported that asthma was not a current condition but had either experienced 
symptoms/treatment in the past 12 months or answered 'yes' to whether they still had asthma 
attacks).  
Information on healthcare service utilization for consultations, including the 
frequency of visits in the past 12 months, was collected for each respondent and each chronic 
condition mentioned above. Self- reported information was collected concerning visits to 
some health professionals [GPs (general practitioners) and specialists (e.g., a cardiologist for 
CVD)], whereas other health professionals (e.g., nurses and social workers) were grouped 
into one category with binary answers reporting whether they had been visited at least once in 
the past 12 months. Information for each HSU was recorded only once for each condition 
group per respondent. However, because the respondent might visit a health professional for 
several different conditions during one visit, the number of visits for different conditions 
could not be summed to estimate total number of visits for a given individual. For example, a 
respondent who reported having visited a GP five times for CVD and two times for diabetes 
might have a total number of GP visits ranging from five to seven.  
Univariate analyses with a 0.25 p-value cut-off were performed to identify covariates 
before the second round of screening, which involved multivariate analyses. A cut-off of a 10% 
change in the exposure variable’s coefficient estimate in the multivariate model was adopted 
to identify “important” variables that influenced the association between the outcome and the 
exposure21. Covariates that remained after these procedures were utilized in all subsequent 
analyses conducted in this study. The following covariates were included in this study: age, 
gender, non-school qualification (having a non-school qualification, including a postgraduate 
degree, graduate diploma/graduate certificate, bachelor degree, advanced diploma/diploma, 
certificate III/IV, or certificate I/II, having a certificate that was not further defined, and not 
having a non-school qualification), and body mass index (BMI=self-reported weight/self-
reported height2). 
Means, frequencies, and percentages were used in the descriptive analyses. To explore 
the associations of multimorbidity and disease-specific healthcare service utilization, logistic 
and Poisson regression models were used to compare individuals who had only one specific 
chronic condition to multimorbid individuals who had that specific chronic condition. Odds 
ratios were estimated from the logistic regression models for visits with other health 
professionals (excluding GPs and specialists), and relative rates were estimated from the 
Poisson regression models for GP and specialist visits.  
To account for non-responses, national representativeness, and confidentiality, all 
analyses were weighted using replicate weights to infer the results for the total in-scope 
Australian population17. All standard errors (SEs) of the estimates were generated by the 
delete-A-group jack-knife technique17. The significance level was set at α=0.05. Multiple 
testing was not adjusted22, as this study is an exploratory study, which is mainly for 
hypothesis generating. The analyses were performed in STATA version 10, special edition 
(StataCorp, College Station, TX, USA)23. 
 
RESULTS 
We analysed data from 10,363 employed participants from a nationally representative 
database. Almost one-quarter of the workforce (23.4%, 95% CI 22.3-24.7) had 
multimorbidity. Of the workforce reporting multimorbidity, 15.2% (95% CI 14.3-16.1) had 
two chronic conditions and 8.2% (95% CI 7.5-8.9) had three or more chronic conditions. The 
most prevalent chronic conditions were CVD at 29.1% (95% CI 27.9-30.4), followed by 
asthma (20.0%, 95% CI 18.9-21.2) and mental disorders (12.5%, 95% CI 11.7-13.2) (Table 
1).  
Compared to employees with single conditions, the employees with multimorbidity 
were more likely to be females for the majority of conditions, relatively older, more likely to 
be educated, less likely to be current smokers, more likely to have a higher BMI, and less 
likely to be white-collar workers. Moreover, the prevalence of multimorbidity increased with 
age but was highest in the 45 to 64-year-old age group. The prevalence also increased with 
the income level, except for cases including mental disorders, which were highest amongst 
those in the middle- income quintile. There were too few cases of osteoporosis and kidney 
disease (21 and 22, respectively) to estimate accurately (the 95% CI ranges were quite large) 
and apply a regression model (Table 2). 
The percentage of employees, who reported visiting a GP at least once in the previous 
12 months prior to the survey interview was higher in most disease groups when 
multimorbidity was present, compared to when only a single condition was present. In 
particular, the employees with multimorbidity were more likely to have a higher number of 
visits. For instance, the employees who visited GPs four times or more times were more 
likely to suffer from multimorbidity for all listed conditions. The percentage of multimorbid 
employees who reported visiting any other health professional at least once in the prior 12 
months was higher for the employees with cancer, arthritis, osteoporosis, CVD, and kidney 
disease than for the employees with only one condition in each condition group (Table 3). 
After controlling for age and gender, multimorbid employees with arthritis had 1.7-
fold (95% CI=1.1-2.2, p<0.001) greater odds of arthritis-specific healthcare service 
utilization of GP visits than employees with arthritis alone. Compared with employees with 
CVD alone, multimorbid employees with CVD had 1.6-fold (95% CI=1.1-2.5, P<0.05) 
greater odds of CVD-specific specialist visits and 2.5-fold (95% CI=1.5-4.0, P<0.001) greater 
odds of CVD-specific visits with other healthcare professionals (Table 4). Overall, our results 
suggested that the pattern of disease-specific healthcare service utilization varied by 
condition.  
 
DISCUSSION 
The descriptive analyses from this nationally representative survey revealed that the 
majority of multimorbid employees reported higher utilization of disease-specific healthcare 
than the employees with one condition alone, which was consistent with previous studies in 
different populations2. While a strong association between multimorbidity and total 
healthcare service utilization is well recognized, this study found that multimorbidity does 
not always increase the healthcare service utilization for a given disease. The association of 
multimorbidity with healthcare service utilization in employees therefore varies by disease 
type. Examination of these nationally representative data is an important part of 
understanding the further healthcare needs of the multimorbid working population, but 
whether these varying healthcare service patterns represent under- or over-utilization of 
particular services cannot be answered from this cross-sectional survey. 
In this study, multimorbid employees with arthritis had more arthritis-specific GP 
visits than employees with arthritis alone, whereas multimorbid employees with CVD were 
not more likely to visit GPs but were more likely to visit CVD specialists than employees 
with CVD alone. Multiple factors can explain these findings. For example, because arthritis 
in itself is inflammatory and its main symptoms are joint pain and stiffness, these symptoms 
may impair a person's ability to perform routine tasks24 25. Therefore, adults with multimorbid 
arthritis are more likely to have adverse outcomes, such as mental distress, and work 
disability than adults without arthritis24. Subsequently, these employees may experience 
greater and more frequent pain, which motivates them to use primary healthcare services 
more often than employees with arthritis alone.  
Multimorbid employees with CVD were more likely to visit healthcare professionals 
(excluding GPs) than employees with CVD alone. One explanation could be that CVD, 
which is the global leading cause of death26, typically manifests in acute events, such as heart 
attacks and strokes27. Therefore, adults with CVD who routinely visit their GPs, especially 
those who are asymptomatic, do not change their service-use models unless they experience 
an emergency. When acute events do occur, these individuals may require tertiary healthcare, 
and the odds of an acute event occurring are compounded when CVD is multimorbid. 
Alternatively, because GPs are considered the “gatekeepers” in the Australian healthcare 
system, people with multimorbid CVD are referred to specialists according to the GP’s 
professional knowledge and opinion even if they are initially asymptomatic and do not 
actively require more healthcare services. 
Coexisting mental-physical disorders lead to higher healthcare service utilization28. 
However, in this study, multimorbid employees with mental and other chronic disorders did 
not report a higher utilization of any healthcare service. This finding could be explained by an 
increase in the utilization of healthcare for physical disorders. In other words, mental 
disorders themselves are already associated with increased healthcare service utilization29, 
and their coexistence with other physical disorders(s) may not further influence the mental 
disorder-specific healthcare needs. However, the presence of mental disorders could 
aggravate a person’s coexisting physical disorders and thus lead to a corresponding increase 
in healthcare service utilization. Because most coexisting physical-mental disorders occur in 
the working-age population6 30, the presence of a mental disorder could increase total 
healthcare service utilization rates by exacerbating a person’s symptoms or perceptions of a 
poor health status even though mental disorder-specific healthcare service utilization did not 
increase due to multimorbidity. Further, pooling all mental disorder types into one category 
may have mediated healthcare service utilization for severe mental disorders, such as major 
depression. Healthcare service utilization for the other conditions did not differ between 
employees with multimorbidity and with single conditions alone.  
In Australia, employees with multimorbid conditions that include arthritis or CVD 
require more attention because their additional needs may lead to new diagnoses, 
prescriptions, and lifestyle changes. Moreover, in the Australian, and other similar healthcare 
systems, GPs are the gatekeepers of healthcare delivery and play an important role in 
managing multimorbidity. Therefore, specialists may be unwilling to share their expertise 
with those outside of their area. Subsequently, to plan for the healthcare of the growing 
number of employees who juggle both employment and chronic conditions, the provision of 
integrated and appropriate services by GPs who closely coordinate their patient’s care should 
remain an area of emphasis for future studies.  
In contrast to the certainty of single diseases, multimorbidity is more changeable and 
there is no “one-size-fits-all” method to address all issues arising from it. Unfortunately, 
health professionals receive no explicit medical education or training in how to prioritize care 
for persons experiencing multimorbidity. Further, the more chronic conditions employees 
have, the more diseases they want to address at each consultation, which makes the health 
professional’s ability to make treatment decisions more difficult. However, the length of a 
standard consultation (5-25 minutes) may not be sufficient for even one disease, and this 
discrepancy may lead to the under-treatment of some conditions, particularly when they co-
exist with others31 32. 
For employees with multimorbidity, setting disease priorities is unavoidable. The 
most important step is to determine whether to identify these diseases explicitly and 
rationally. The needs of an individual with multimorbidity may vary substantially over their 
life course. Therefore, individuals with CVD or arthritis of working age need more attention 
and may gain greater health improvements if being managed appropriately. Moreover, the 
Australian National Health Survey used in this study measured healthcare use for each health 
conditions, which prohibit the use of “normal” count-based or cluster-based methods of 
defining multimorbidity33. As such, current national population data collection may not 
address the identified gap. As Tinetti et al (2012) suggest “healthcare should but not shift its 
current focus from a disease orientation to a patient goal orientation”34 and must be updated 
to align with the clinical reality of multimorbidity.  
This study also revealed the prevalence of multimorbidity in the workforce was 
consistent with previous studies35 and, whilst it increased with age, was highest in the 45 to 
64-year-old age group. This result may have occurred because the employees in this age 
group are more likely to consent to early retirement when experiencing from multimorbidity. 
However, the pension they receive may not be sufficient to support their heavy health and 
economic burdens due to multimorbidity. This could lead to multimorbid employees 
remaining in the workforce in order to cover the costs associated with their diseases in the 
very near future36. 
Given no agreed definition, using the other methods to define multimorbidity may 
have produced different results. For example, using the higher cut-off may strengthen the 
negative association of multimorbidity with HSU, and it is possible that more health 
conditions would be identified in addition to arthritis and CVD in this study. However, the 
three cut-off requires more included health conditions and is more appropriate to older 
populations whereas the two cut-off is more appropriate in populations with a broader age 
scope37. Another popular method is questionnaire-based, such as the Cumulative Illness 
Rating Scale38 and Charlson Index39 which require additional mapping of diagnoses from the 
classification system37. So it is impossible to access these scales if the survey like the NHS 
2011-12 does not incorporate them. 
A notable limitation of this study was the use of cross-sectional data which meant 
neither directionality nor temporality could be attributed to the associations between variables, 
and causal relationships could not be determined. Further, this study was based on self-
reported data. That is, diagnoses and healthcare service utilization were not clinically verified 
by professionals, and the participants were asked only about main conditions to reduce recall 
bias17. However, some conditions were likely under-reported due to stigma (e.g., mental 
disorders) and the presence of “silent” conditions (e.g., mental/behavioural disorders or 
diabetes)40. Finally, due to the confidential purpose and the complex multistage cluster 
sampling of the NHS 2011-12 data, some statistical processing such as the differences test 
between two groups was not allowed within the ABS on-line data query environment, which 
may lead to interpretation difficulty to some extent. However, we provided the 95% CI of 
each estimate to present the magnitude of difference.  
The strengths of this study included the use of nationally representative data, which 
covered approximately 97% of the people living in Australia at the time of the NHS17. This 
broad coverage increases the generalizability of the findings. In contrast to other studies40 41, 
this study explored multimorbidity not only in the working-age population but also in a 
population who were actually employed at the time of survey completion. This distinction 
could exclude working-age people who were not in the workforce, who likely had different 
healthcare service utilization needs, and who were not influenced by work-related factors. 
 
CONCLUSION  
This study is the first to examine the associations between multimorbidity and 
disease-specific healthcare service utilization using a nationally representative sample of 
employees and a series of chronic conditions. Multimorbidity was common in this population. 
Compared with individuals with other diseases, employees with multimorbid conditions 
including arthritis or CVD required more attention in understanding the associations between 
multimorbidity and health service use. Guidelines for the management of multimorbidity are 
urgently needed, especially with the inevitable economic burden imposed by the ageing 
workforce. Longitudinal studies are recommended to understand the progression and impact 
of multimorbidity on healthcare resource utilization over time. However, the very first and 
most important step is updating the way of data collection to align with the clinical reality of 
multimorbidity. 
  
Table 1. Distribution of socio-demographic characteristics and health conditions in the Australian 
working population (2011-12).  
 n % (95% CI) 
Total  10,363  
   
Male (vs. female)  5,344 54.4 (53.7-55.1)    
   
Age   
Mean (years old)  39 
 15-24 yrs. 1,274 16.5 (15.9-17.1)    
 25-34 yrs. 2,224 22.4 (21.9-22.9)    
 35-44 yrs. 2,464 22.1 (21.7-22.5)    
 45-54 yrs. 2,370 21.4 (21.1-21.8)    
 55-64 yrs. 1,625 14.2 (13.7-14.6)    
 65+ yrs. 406 3.4 (3.0-3.8)    
   
Married (vs. unmarried)  4,908 52.3 (51.0-53.6)    
Has educational attainment (vs. do not has) 7,016 67.6 (66.4-68.8)    
Current smoker (vs. non-smoker) 2,038 18.5 (17.6-19.4)    
   
BMI   
 Thin (>=18.5) 96 1.3 (0.9-1.6)    
 Normal (18.5-24.99) 3,135 36.8 (35.5-38.1)    
 Overweight (25-29.99) 3,160 35.4 (34.1-36.6)    
 Obesity (>=30) 2,336 26.5 (25.5-27.6)    
    
White-collar (vs. blue-collar) 7,377 69.3 (68.0-70.5)    
   
Gross weekly income level   
 1st-lowest 780 9.5 (8.7-10.3)    
 2nd  995 12.3 (11.5-13.1)    
 3rd  2,059 23.7 (22.5-24.9)    
 4th  2,613        26.8 (25.4-28.2)    
 5th-highest 2,787        27.8 (26.6-28.9)    
   
Chronic Conditions   
CVD 3,175 29.1 (27.9-30.4) 
Asthma 2,150 20.0 (18.9-21.2) 
Mental disorder 1,386 12.5 (11.7-13.2) 
Arthritis 1,295 11.4 (10.7-12.2) 
Cancer  1,070 9.1 (8.4-9.8) 
Diabetes 808 7.1 (6.5-7.7) 
Osteoporosis 204 1.5 (1.2-1.8) 
Kidney disease 148 1.3 (1.0-1.6) 
   
Number of chronic conditions   
 0 4,163 42.4 (41.2-43.7) 
 1 3,506 34.1 (32.9-35.3) 
 2 1,726 15.2 (14.3-16.1) 
 3+ 968 8.2 (7.5-8.9) 
 
CVD=cardiovascular disease. Sample size (n) are showed with crude data, percentage of chronic conditions are 
estimated with weighting strategy. The sample size of working participants was 10,363. 
     
  
Table 2 Distribution of socio-demographic characteristics by morbidity category in a national working 
population 
 Asthma Cancer CVD Arthritis 
 Only In MM Only In MM Only In MM Only In MM 
 n=975 n=1175 n=304 n=766 n=1,258 n=1917 n=325 n=970 
Male (vs. female)  58.2 (54.0-62.5) 44.1 (41.2-47.1) 54.8 (47.9-61.8) 50.4 (45.8-54.9) 54.3 (51.1-57.5) 49.0 (46.3-51.8) 56.2 (49.4-63.1) 44.3 (40.2-48.4) 
         
Age         
 15-24 yrs. 28.6 (25.0-32.2) 11.2 (8.4-14.1) 2.6 (0-5.4) 1.3 (0.1-2.5) 5.9 (3.7-8.0) 4.4 (2.8-6.1) 4.0 (0.4-7.7) 1.0 (0.3-1.6) 
 25-34 yrs. 33.6 (29.9-37.4) 20.8 (18.1-23.6) 6.8 (3.3-10.4) 7.1 (5.0-9.3) 18.7 (15.6-21.7) 9.8 (8.4-11.3) 8.9 (4.9-13.0) 7.0 (5.1-8.9) 
 35-44 yrs. 19.5 (16.2-22.8) 22.3 (19.3-25.4) 28.9 (22.2-35.6) 13.0 (9.8-16.2) 23.9 (21.0-26.8) 18.0 (16.2-19.9) 16.6 (10.5-22.8) 11.0 (8.4-13.6) 
 45-54 yrs. 12.7 (10.0-15.4) 22.1 (19.8-24.5) 32.9 (27.0-38.8) 24.4 (20.7-28.1) 28.3 (26.2-30.5) 28.4 (26.2-30.5) 33.8 (26.2-41.3) 29.4 (25.9-32.9) 
 55-64 yrs. 5.2 (3.7-6.8) 18.9 (16.1-21.6) 23.1 (16.9-29.3) 40.2 (35.9-44.5) 18.9  (16.6-21.2) 30.5 (28.3-32.8) 27.6 (21.3-33.9) 39.4 (35.8-42.9) 
 65+ yrs. 0.3 (0-0.6) 4.6 (3.2-6.0) 5.7 (2.7-8.6) 13.9 (10.2-17.6) 4.3 (3.2-5.4) 8.8 (7.2-10.3) 9.0 (4.5-13.6) 12.3 (9.7-14.9) 
         
 Married (vs. unmarried) 39.6 (35.9-43.3) 49.2 (45.1-53.3) 67.7 (61.9-73.5) 65.5 (61.0-70.0) 64.8 (60.9-68.7) 61.8 (58.6-65.0) 67.0 (60.1-74.0) 64.0 (59.7-68.3) 
         
 Has educational attainment (vs. 
do not has) 
65.9 (62.2-69.6) 72,2 (68.9-75.8) 70.3 (64.4-76.2) 73.1 (69.2-77.1) 71.3 (68.3-74.3) 69.3 (66.6-72.0) 57.8 (49.1-66.4) 69.1 (65.5-72.6) 
         
 Current smoker (vs. non-smoker)  19.3 (15.8-22.7) 20.9 (17.9-23.9) 17.2 (12.5-22.0) 15.6 (11.9-19.3) 16.7 (14.0-19.4) 16.1 (14.2-18.0) 20.6 (14.1-27.0) 16.4 (13.1-19.6) 
         
BMI         
 Thin (>=18.5) 1.7 (0.5-2.9) 1.3 (0.2-2.3) 1.6 (0-4.6) 0.1 (0-0.2) 0.6 (0-1.2) 0.6 (0-1.1) 0.6 (0-1.3) 0.3 (0-0.8) 
 Normal (18.5-24.99) 40.5 (35.4-45.7) 29.6 (25.7-33.6) 35.1 (27.3-42.9) 26.3 (21.5-31.1) 29.9 (26.6-33.1) 23.1 (20.3-25.9) 23.5 (17.3-29.8) 21.4 (17.7-25.1) 
 Overweight (25-29.99) 37.3 (32.9-41.7) 34.2 (30.1-38.3) 40.8 (33.4-48.1) 36.7 (31.6-41.8) 38.9 (35.5-42.3) 35.6 (32.0-39.2) 44.5 (36.0-53.0) 33.1 (28.3-38.0) 
 Obesity (>=30) 20.4 (17.1-23.8) 34.8 (30.9-38.8) 22.5 (16.5-28.5) 36.9 (32.5-41.4) 30.6 (27.4-33.8) 40.7 (37.9-43.5) 31.4 (24.4-38.5) 45.1 (40.7-49.5) 
          
White-collar (vs. blue-collar) 30.8 (26.6-35.0) 24.4 (21.6-27.2) 25.9 (19.8-32.0) 28.8 (24.5-33.1) 31.1 (27.5-34.6) 25.9 (23.5-28.3) 39.3 (30.8-47.8) 28.8 (25.2-32.3) 
         
Gross weekly income level          
 1st-lowest 12.7 (9.9-15.5) 7.2 (5.1-9.2) 6.9 (2.7-11.1) 4.7 (2.7-6.7) 6.3 (4.3-8.3) 5.5 (4.0-6.9) 8.7 (4.6-12.7) 6.2 (4.4-7.9) 
 2nd  13.1 (10.1-16.0) 13.1 (10.6-15.7) 8.9 (4.5-13.2) 14.1 (10.7-17.4) 10.0 (7.7-12.3) 13.3 (11.2-15.4) 16.0 (9.1-22.9) 15.7 (12.2-19.1) 
 3rd  22.1 (18.4-25.7) 24.6 (21.2-28.1) 20.9 (14.1-27.8) 22.4 (18.0-26.7) 22.3 (18.8-25.8) 21.8 (18.6-25.1) 19.9 (14.3-25.6) 25.0 (20.5-29.6) 
 4th  30.9 (27.1-34.7) 27.9 (24.5-31.2) 30.6 (22.7-38.4) 25.6 (21.1-30.0) 28.0 (23.2-32.8) 26.9 (24.1-29.7) 27.6 (19.8-35.4) 27.0 (22.7-31.4) 
 5th-highest 21.2 (18.1-24.3) 27.2 (23.7-30.7) 32.8 (25.5-40.0) 33.3 (28.8-37.9) 33.4 (29.3-37.5) 32.5 (29.5-35.4) 27.8 (21.2-34.4) 26.1 (22.3-30.0) 
 
MM=multimorbid ity. CVD=cardiovascular disease. BMI=Body mass index. Values are % (95%CI). Sample 
size (n) are showed with crude data, percentage and mean times of v isits are estimated with weighting strategy. 
The sample size of working participants was 10,363.  
Table 2 (continue) 
 Osteoporosis Diabetes Kidney Mental  
 Only In MM Only In MM Only In MM Only In MM 
 n=21 n=183 n=191 n=617 n=22 n=126 n=410 n=976 
Male (vs. female)  36.2 (10.2-62.2) 26.4 (18.1-34.6) 47.6 (38.2-57.1) 54.8 (50.1-59.5) 40.6 (8.9-72.2) 43.5 (31.8-55.3) 53.2 (47.0-59.5) 43.0 (39.0-47.0) 
         
Age         
 15-24 yrs. 6.8 (0-20.9) 0.1 (0-0.3) 8.2 (2.3-14.2) 6.0 (2.8-9.3) 23.9 (0-60.6) 3.8 (0.3-7.3) 25.6 (18.9-32.4) 9.6 (6.8-12.3) 
 25-34 yrs. - 4.4 (0-9.4) 20.5 (13.9-27.0) 8.0 (5.1-11.0) 9.9 (0-29.0) 7.7 (2.9-12.5) 24.2 (18.6-29.8) 17.9 (15.1-20.8) 
 35-44 yrs. 40.0 (0-66.3) 8.1 (2.0-14.2) 26.9 (18.1-35.6) 19.5 (15.1-23.9) 28.0 (0.6-55.4) 12.3 (4.9-19.7) 26.6 (20.6-32.6) 23.3 (19.9-26.7) 
 45-54 yrs. 15.6 (0-32.7) 27.4 (19.0-35.8) 24.4 (15.9-32.8) 29.6 (25.4-33.8) 23.3 (0-51.1) 43.8 (31.7-55.9) 14.1 (10.0-18.3) 27.2 (23.2-31.1) 
 55-64 yrs. 25.4 (0.9-49.9) 48.4 (38.4-58.4) 17.4 (8.6-26.2) 28.3 (23.9-32.7) 15.0 (0-33.9) 21.6 (13.7-29.6) 8.2 (5.1-11.4) 17.7 (14.5-20.8) 
 65+ yrs. 12.2 (0-28.9) 11.6 (6.4-16.9) 2.7 (0.6-4.7) 8.5 (6.1-11.0) - 10.8 (4.3-17.3) 1.2 (0-2.5) 4.3 (2.5-6.2) 
         
 Married (vs. unmarried) 33.5 (8.4-58.6) 62.8 (55.4-70.3) 65.7 (57.3-74.1) 58.7 (53.3-64.1) 34.3 (3.8-64.7) 60.4 (49.2-71.7) 33.3 (27.4-39.1) 49.6 (45.1-54.1) 
         
 Has educational attainment (vs. do 
not has) 
53.1 (24.8-81.5) 71.8 (63.0-80.6) 72.1 (64.3-80.0) 69.7 (64.4-75.1) 82.3 (57.7-100) 73.8 (63.6-84.1) 65.3 (58.9-71.8) 70.7 (66.6-74.8) 
         
 Current smoker (vs. non-smoker)  3.9 (0-12.0) 16.4 (10.1-22.7) 21.7 (14.2-29.1) 15.9 (12.3-19.4) 17.4 (0-42.7) 12.8 (5.7-19.9) 30.0 (24.2-35.7) 26.4 (22.5-30.3) 
         
BMI         
 Thin (>=18.5) - 1.7 (0-5.2) - 0.4 (0-1.2) - - 2.1 (0.2-3.9) 1.0 (0.1-1.8) 
 Normal (18.5-24.99) 64.0 (29.2-98.7) 35.1 (24.2-45.9) 31.1 (22.3-40.0) 11.2 (7.6-14.8) 51.5 (12.2-90.9) 25.3 (14.5-36.1) 41.4 (34.5-48.2) 28.0 (23.8-32.3) 
 Overweight (25-29.99) 36.0 (1.3-70.8) 38.6 (26.2-51.1) 34.3 (24.7-43.9) 34.2 (28.5-39.9) 14.1 (0-31.5) 34.9 (23.7-46.0) 27.6 (22.3-32.9) 34.1 (29.1-39.1) 
 Obesity (>=30) - 24.6 (15.3-33.9) 34.6 (25.0-44.2) 54.3 (48.7-59.9) 34.4 (0-70.4) 39.8 (26.9-52.8) 29.0 (22.1-35.8) 36.9 (32.3-41.5) 
          
White-collar (vs. blue-collar) 20.2 (0.5-40.0) 16.4 (8.8-24.0) 28.5 (20.7-36.4) 28.0 (23.5-32.5) 24.0 (0-53.2) 28.4 (19.8-36.9) 30.8 (23.6-38.0) 26.8 (23.4-30.2) 
         
Gross weekly income level          
 1st-lowest 3.8 (0-11.7) 7.8 (2.1-13.6) 10.7 (2.8-18.5) 8.4 (5.0-11.8) 16.0 (0-42.0) 7.7 (1.4-14.0) 13.4 (7.9-18.8) 7.2 (5.0-9.5) 
 2nd  4.9 (0-15.3) 17.2 (10.4-24.0) 10.3 (4.2-16.3) 12.8 (8.9-16.7) 46.7 (3.2-90.2) 16.3 (6.9-25.8) 14.3 (8.8-19.7) 14.1 (10.8-17.4) 
 3rd  32.6 (3.1-62.1) 23.4 (14.2-32.6) 25.5 (16.1-34.9) 23.8 (18.6-28.9) 5.9 (0-16.7) 27.0 (16.4-37.7) 27.3 (20.7-33.9) 30.1 (26.3-33.8) 
 4th  42.9 (10.7-75.1) 27.3 (18.9-35.7) 28.0 (18.8-37.1) 27.7 (23.0-32.3) 22.6 (0-49.8) 15.2 (8.1-22.2) 25.2 (19.3-31.0) 25.6 (21.9-29.3) 
 5th-highest 15.8 (0-37.7) 24.2 (16.2-32.3) 25.6 (18.1-33.1) 27.4 (22.5-32.3) 8.7 (0-22.4) 33.7 (21.3-46.2) 19.9 (14.6-25.2) 23.0 (19.6-26.5) 
 
MM=multimorbid ity. CVD=cardiovascular disease. BMI=Body mass index. Values are % (95%CI). Sample 
size (n) are showed with crude data, percentage and mean times of v isits are estimated with weighting strategy. 
The sample size of working participants was 10,363. 
 
 
 
 
  
Table 3 12-month disease-specific healthcare service utilization of GPs, specialists and other health 
professionals by disease status (alone and coexisting with other conditions) 
 Asthma Cancer CVD Arthritis 
 Only In MM Only In MM Only In MM Only In MM 
 n=975 n=1175 n=304 n=766 n=1258 n=1917 n=325 n=970 
Disease-specif ic          
GP visits         
0 visit  59.0 (52.6-65.4) 56.0 (50.2-61.8) 36.7 (3.1-70.2) 31.3 (17.0-45.7) 37.4 (32.3-42.5) 36.0 (31.1-40.9) 62.7 (53.2-72.2) 57.8 (52.6-63.1) 
1 visit 24.4 (18.4-30.3) 22.1 (17.7-26.4) 23.3 (3.8-42.9) 32.9 (18.8-47.1) 20.0 (15.8-24.1) 19.7 (16.5-22.9) 27.5 (18.0-36.9) 21.2 (16.8-25.5) 
2 visits  7.5 (4.5-10.5) 11.7 (8.3-15.1) 8.6 (0-27.3) 21.0 (7.6-34.4) 25.0 (20.5-29.5) 20.0 (16.1-23.8) 6.4 (2.2-10.5) 9.8 (6.8-12.7) 
3 visits  6.2 (3.3-9.1) 4.2 (2.1-6.3) 0.6 (0-2.0) 5.0 (0-11.1) 6.3 (3.6-9.0) 6.9 (4.6-9.2) 1.8 (0-3.7) 4.5 (2.7-6.3) 
4+ visits  2.9 (1.1-4.7) 6.0 (3.5-8.6) 30.8 (0-65.9) 9.8 (1.2-18.4) 11.4 (7.9-14.9) 17.4 (14.1-20.6) 1.7 (0.1-3.3) 6.8 (4.9-8.7) 
Specialist visits         
0 visit  98.0 (96.7-99.3) 96.6 (94.8-98.3) 45.9 (13.3-78.6) 42.9 (24.9-61.0) 87.3 (84.0-90.6) 85.0 (81.9-88.1) 80.2 (71.9-88.6) 85.8 (82.8-88.9) 
1 visit  1.2 (0.1-2.2) 1.8 (0.6-3.0) 19.4 (0-39.6) 17.2 (1.2-33.2) 7.9 (5.5-10.3) 8.8 (6.2-11.4) 6.4 (1.8-10.9) 7.3 (5.0-9.6) 
2+ visits  0.8 (0-1.7) 1.6 (0.3-3.0) 34.7 (7.9-61.5) 39.8 (24.0-55.7) 4.8 (2.3-7.3) 6.2 (4.2-8.2) 13.4 (6.4-20.4) 6.9 (4.6-9.1) 
Visit other HP at least once 10.1 (6.1-14.1) 6.1 (3.9-8.3) 24.2 (0-53.0) 26.6 (13.0-40.2) 4.4 (2.4-6.3) 9.9 (7.9-12.0) 17.4 (10.6-24.3) 20.1 (16.4-23.8) 
 Osteoporosis Diabetes Kidney Mental  
 Only In MM Only In MM Only In MM Only In MM 
 n=21 n=183 n=191 n=617 n=22 n=126 n=410 n=976 
Disease-specif ic HSU         
GP visits         
0 visit  57.3 (29.3-85.3) 45.5 (36.2-54.8) 19.9 (5.2-34.5) 18.1 (9.9-26.3) 42.1 (0-100) 62.1 (40.4-83.8) 37.3 (28.5-46.0) 38.6 (33.5-43.7) 
1 visit  33.2 (6.4-60.1) 28.6 (19.6-37.5) 19.0 (6.5-31.5) 17.9 (11.7-24.2) 33.4 (0-89.3) 12.8 (0-26.2) 24.6 (15.2-33.9) 18.9 (14.5-23.3) 
2 visits  9.4 (0-29.3) 16.7 (6.8-26.6) 23.3 (7.6-38.9) 26.2 (17.3-35.1) - 9.6 (0-22.5) 16.6 (9.9-23.4) 14.6 (10.7-18.5) 
3 visits  - 3.6 (0-7.3) 11.7 (0-25.4) 10.0 (5.0-14.9) 24.5 (0-81.5) 1.8 (0-5.5) 8.7 (5.0-16.8) 9.9 (6.8-13.0) 
4+ visits  - 5.6 (1.0-10.3) 26.1 (8.9-43.3) 27.8 (20.3-35.3) - 13.7 (1.3-26.1) 12.9 (6.7-19.0) 18.0 (14.7-21.2) 
Specialist visits         
0 visit  100 (100-100) 86.5 (79.2-93.8) 60.7 (44.4-76.9) 76.7 (68.7-84.8) 59.2 (0-100) 49.4 (30.9-68.0) 80.4 (73.3-87.4) 80.0 (76.2-83.6) 
1 visit  - 6.1 (1.8-10.4) 17.1 (2.2-32.0) 7.2 (2.8-11.5) 40.8 (0-100) 20.1 (0.4-39.9) 4.3 (0.9-7.6) 3.9 (2.3-5.6) 
2+ visits  - 7.4 (1.8-12.9) 22.2 (9.1-35.3) 16.1 (9.1-23.1) - 30.4 (14.2-46.6) 15.3 (9.0-21.7) 16.2 (12.4-19.9) 
Visit other HP at least once  10.4 (0-22.3) 13.4 (6.6-20.2) 42.8 (26.2-59.3) 38.1 (30.0-46.3) - 2.5 (0-5.8) 28.5 (20.9-36.1) 26.5 (22.8-30.3) 
GP=general pract itioner. HP=health professional. MM=mult imorb idity. CVD=cardiovascular disease. 
HSU=healthcare service utilizat ion. Values are % (95%CI). The sample size of working participants was 10,363.  
 
  
Table 4 Multivariate analysis of disease-specific healthcare service utilization of GPs, specialists and 
other health professionals associated with employees with specific condition only compared to those 
with specific condition coexisting with other chronic conditions  
 GPs  specialists  Other HPs  
 RR (95% CI) p RR (95% CI) p OR (95% CI) p 
Asthma N=1087  N=1166  N=1171  
  Only 1.0  1.0  1.0  
  In MM 1.0 (0.7,1.2) 0.823 0.7 (0.2,2.6) 0.634 0.7 (0.4,1.2) 0.160 
       
Cancer N=89  N=90  N=112  
  Only 1.0  1.0  1.0  
  In MM 0.7 (0.1,1.3) 0.365 1.2 (0.5,2.9) 0.749 1.4 (0.1,14.0) 0.796 
       
CVDa N=1302  N=1718  N=1750  
  Only 1.0  1.0  1.0  
  In MM 1.1 (0.8,1.2) 0.680 1.6 (1.1,2.5) 0.03 2.5 (1.5,4.0) <0.001 
       
Arthritisb N=835  N=1031  N=1056  
  Only 1.0  1.0  1.0  
  In MM 1.7 (1.1,2.2) <0.001 0.9 (0.4,1.8) 0.728 1.2 (0.7,2.1) 0.453 
       
Diabetes N=268  N=317  N=329  
  Only 1.0  1.0  1.0  
  In MM 0.9 (0.5,1.2) 0.540 1.0 (0.4,2.3) 0.999 0.9 (0.4,2.0) 0.796 
       
Mental disorder N=814  N=873  N=935  
  Only 1.0  1.0  1.0  
  In MM 1.2 (0.9,1.5) 0.262 0.5 (0.8,2.8) 0.163 1.0 (0.7,1.4) 0.839 
 
GP=general pract itioner. HP=health professional. MM=multimorbidity. CVD=card iovascular disease. Poisson 
regression models were used for the relationship between the number of visits with GP, specialists and the 
multimorbidity status. Logistic regression models were used for the relationship between the number of visits 
with other HP and the mult imorbid ity status. Significant estimates are typed in bold font (p<0.05). Sample size 
(n) are showed with crude data, rate rat ios (RR) and odds ratios (OR) are estimated with weighting strategy. The 
sample size of working participants was 10,363.  
All models adjusted for age and sex, models additionally adjusted for: a: BMI; b : educational attainment and 
BMI.  
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